CurveBeam AI Limited (CVB.AX)

Full history for every metric is available with a Kvantra account

Stock profile
CurveBeam AI Limited logo

CurveBeam AI Limited (CVB.AX)

Country: United States of AmericaSector: HealthcareIndustry: Medical - DevicesExchange: ASX
P/E TTM
N/A
History
P/E NTM
N/A
Market cap
18.43M
Currency AUD
KvantraRankAboutN/ANot enough data to calculate KvantraRank
IValueN/A
IIQualityN/A
IIIMomentumN/A
Current price
0.02 AUD-4.17%
Benchmarks

No price history available.

Key financial summary

Financials in AUDTTM unavailable because four recent quarterly reports are not available
202020212022202320242025TTM2026E
Total revenueAUD m--------
Operating profitAUD m-
Net profitAUD m--------
EPS reportedAUD-
Operating cashflow per shareAUD-
Capex per shareAUD-
FCF per shareAUD-
Free cash flowAUD m-
Net debtAUD m-
Book value equityAUD m-
Book value per shareAUD-
Number of sharesm-
DPS (TTM paid)AUD-

Financial summary

Financials in AUDTTM unavailable because four recent quarterly reports are not available
202020212022202320242025TTM2026E
Value
P/E TTMx-
P/B LTMx-
P/S LTMx-
P/FCF LTMx-
EV/EBITDA LTMx-
EV/Sales LTMx-
Earnings Yield LTM%-
FCF Yield%-
Quality
ROE%-
ROIC%-
Operating margin%-
Gross margin%-
FCF/Sales%-
Growth and momentum
EPS Growth YoY%-
Sales Growth YoY%-
Net Income Growth YoY%-
FCF Growth%-
Operating Profit Growth%-
Dividend and capital structure
Dividend Yield%-
Dividend Growth%-
Payout Ratio%-
FCF/Debtx-
Net Debt/EBITDAx-
EBIT/Net interestx-
Net debt/market cap%-
Net debt/Equityx-
Gross debt/equityx-

Price target estimates

Low estimate
High estimate
Price consensus
Last year average price target
Current price0.02 AUD
Return Potential

Based on consensus from external analysts. Not Kvantra's opinion.

Ratings

Strong Buy
Buy
Hold
Sell
Strong Sell
Number of covering analysts

Based on consensus from external analysts. Not Kvantra's opinion.

ESG

Metric202420252026
ESG-score
Environmental score
Social score
Governance score
Risk rating

Company overview

CurveBeam AI Limited engages in the development and manufacture of point-of care specialized weight bearing medical imaging equipment in Europe, North America, and internationally. The company offers HiRise for bilateral weight bearing CT imaging; LineUP, a bilateral, weight bearing CT imaging of the knees and lower extremities for orthpedic practices; pedCAT Premium and pedCAT for imaging of the foot and ankle; InReach, a point-of-care extremity CT imaging which assess the distal extremities with 3D clarity at a fraction of the dose; and CubeVue Software visualization tools. It also provides software CurveBeam AI Autometrics for automatically segment foot and ankle datasets; Axiometrics, provides a semi-automatic measurement of the axes of rotation of the hip, femur, knee, and ankle; and TALAS, a measurement tool that semi-automatically calculate hindfoot alignment based on reproducible three-dimensional anatomical landmarks. In addition, the company offers custom web-based cloud platform; and OSSView. The company was incorporated in 2009 and is headquartered in Hatfield, Pennsylvania.

SectorHealthcare
IndustryMedical - Devices
CountryUnited States of America
Trades inAUD

Similar companies

For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.

CurveBeam AI Limited (CVB.AX)

CVB.AX · ASX · Healthcare
0.02 AUD-4.17%
Sign up to track this stock

No price history available.

KvantraRankN/A
Market cap18.43M
P/E NTMN/A
P/E TTMN/A
KvantraRank?

Not enough data to calculate KvantraRank

Financialsin AUD
TTM unavailable because four recent quarterly reports are not available.
20242025TTM2026E
Analyst target
Consensus
Current0.02 AUD
Upside
Price consensus
Last year average price target
Current price0.02 AUD
Return Potential

Consensus from external analysts. Not Kvantra's opinion.

Ratings
Strong Buy
Buy
Hold
Sell
Strong Sell

Based on consensus from external analysts. Not Kvantra's opinion.

ESG
202420252026
ESG-score
Environmental score
Social score
Governance score
Risk rating
About

CurveBeam AI Limited engages in the development and manufacture of point-of care specialized weight bearing medical imaging equipment in Europe, North America, and internationally. The company offers HiRise for bilateral weight bearing CT imaging; LineUP, a bilateral, weight bearing CT imaging of the knees and lower extremities for orthpedic practices; pedCAT Premium and pedCAT for imaging of the foot and ankle; InReach, a point-of-care extremity CT imaging which assess the distal extremities with 3D clarity at a fraction of the dose; and CubeVue Software visualization tools. It also provides software CurveBeam AI Autometrics for automatically segment foot and ankle datasets; Axiometrics, provides a semi-automatic measurement of the axes of rotation of the hip, femur, knee, and ankle; and TALAS, a measurement tool that semi-automatically calculate hindfoot alignment based on reproducible three-dimensional anatomical landmarks. In addition, the company offers custom web-based cloud platform; and OSSView. The company was incorporated in 2009 and is headquartered in Hatfield, Pennsylvania.

SectorHealthcare
IndustryMedical - Devices
CountryUnited States of America
Trades inAUD

For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.

Unlock all fundamental data

Sign up for Free

Unlock all fundamental data

Sign up for Free